Saturday, January 30, 2010

Corrupt marketing practices at Lilly and AstraZeneca


"Drug marketing is a very sophisticated system which corrupts every part of the scientific and medical network," says Australian psychiatrist Peter Parry. A new study in the Journal of Bioethical Inquiry by Parry and Metropolitan State University (Minnesota) psychology professor Glen Spielmans suggests the extent to which antipsychotic drugmakers have manipulated and distorted medical evidence about their drugs.

No comments: